ArticleScience translational medicine2012

Structure-guided design of a high-affinity platelet integrin αIIbβ3 receptor antagonist that disrupts Mg²⁺ binding to the MIDAS.

Jieqing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.